These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44 related articles for article (PubMed ID: 3108094)
1. Spontaneous deep haematomas in two patients with myelofibrosis. Evidence of platelet membrane glycoprotein modifications. Landolfi R; De Cristofaro R; Castagnola M; Cudillo L; Scribano D; Leone G Haematologica; 1987; 72(1):45-8. PubMed ID: 3108094 [No Abstract] [Full Text] [Related]
2. [Inhibition of platelet aggregation with monoclonal antibodies to the glycoprotein IIb-IIIa complex]. Byzova TV; Vlasik TN; Mazurov AV Biull Eksp Biol Med; 1994 Oct; 118(10):402-5. PubMed ID: 7865820 [No Abstract] [Full Text] [Related]
3. [Thrombocytes and aging. Protein and neuraminic acid content of thrombocytes of male donors of various age groups]. Hager K; Breidung R Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):646-55. PubMed ID: 2448205 [TBL] [Abstract][Full Text] [Related]
4. Preliminary study showing the relationship between platelet fibronectin, sialic acid, and ADP-induced aggregation levels in coronary heart disease. Bütün II; Ekmekçi H; Sönmez H; Gürel C; Ciftçi O; Ulutin T; Kökoğlu E; Domaniç N; Dirican A Clin Appl Thromb Hemost; 2007 Jul; 13(3):308-12. PubMed ID: 17636193 [TBL] [Abstract][Full Text] [Related]
6. Platelet abnormalities in idiopathic myelofibrosis: functional, biochemical and immunomorphological correlations. Leoni P; Rupoli S; Lai G; Brunelli MA; Belmonte MM; Pugnaloni A; Rabini RA; Mazzanti L; Biagini G Haematologica; 1994; 79(1):29-39. PubMed ID: 15378946 [TBL] [Abstract][Full Text] [Related]
7. The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active. Cook NS; Bruttger O; Pally C; Hagenbach A Thromb Haemost; 1993 Nov; 70(5):838-47. PubMed ID: 8128443 [TBL] [Abstract][Full Text] [Related]
8. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions. Oliver JA; Albrecht RM Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571 [TBL] [Abstract][Full Text] [Related]
9. Impact of tobacco smoking on platelet function in apheresis products in vitro. Scheinichen D; Heuft HG; Renken C; Jüttner B; Jaeger K; Schürholz T; Blasczyk R; Piepenbrock S; Elsner HA Vox Sang; 2004 May; 86(4):252-6. PubMed ID: 15144530 [TBL] [Abstract][Full Text] [Related]
10. von Willebrand factor can substitute for plasma fibrinogen in ADP-induced platelet aggregation. Timmons S; Hawiger J Trans Assoc Am Physicians; 1986; 99():226-35. PubMed ID: 3496699 [No Abstract] [Full Text] [Related]
11. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists. Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560 [TBL] [Abstract][Full Text] [Related]
12. Influence of platelet membrane sialic acid and platelet-associated IgG on ageing and sequestration of blood platelets in baboons. Kotzé HF; van Wyk V; Badenhorst PN; Heyns AD; Roodt JP; Lötter MG Thromb Haemost; 1993 Oct; 70(4):676-80. PubMed ID: 8115995 [TBL] [Abstract][Full Text] [Related]
13. Platelet aggregation in platelet rich plasma and whole blood in 18 patients affected by idiopathic myelofibrosis. Balduini CL; Bertolino G; Gamba G; Barosi G; Sinigaglia F; Noris P; Bisio A; Ascari E Eur J Haematol; 1988 Sep; 41(3):267-72. PubMed ID: 3181398 [TBL] [Abstract][Full Text] [Related]
14. A comparison of spontaneous platelet aggregation in whole blood with platelet rich plasma: additional evidence for the role of ADP. Saniabadi AR; Lowe GD; Barbenel JC; Forbes CD Thromb Haemost; 1984 Feb; 51(1):115-8. PubMed ID: 6719381 [TBL] [Abstract][Full Text] [Related]
15. An antiplatelet monoclonal antibody that inhibits ADP and epinephrine-induced aggregation. Vilella R; Lozano T; Mila J; Borche L; Ercilla G; Ordinas T; Vives J Thromb Haemost; 1984 Feb; 51(1):93-6. PubMed ID: 6232732 [TBL] [Abstract][Full Text] [Related]
16. Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome. Bigalke B; Geisler T; Stellos K; Langer H; Daub K; Kremmer E; Seizer P; May AE; Lindemann S; Gawaz M Am Heart J; 2008 Jul; 156(1):193-200. PubMed ID: 18585516 [TBL] [Abstract][Full Text] [Related]
17. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention. Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C Am J Cardiol; 2006 Jan; 97(1):38-43. PubMed ID: 16377281 [TBL] [Abstract][Full Text] [Related]
18. [Limits of platelet aggregation tests for investigating thromboses (author's transl)]. Sie P; Cousin F; Barret A; Caranobe C; Boneu B; Bierme R Nouv Presse Med; 1980 Oct; 9(36):2629-32. PubMed ID: 7433051 [TBL] [Abstract][Full Text] [Related]
19. Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders. Yamamoto K; Sekiguchi E; Takatani O Thromb Haemost; 1984 Dec; 52(3):292-6. PubMed ID: 6531753 [TBL] [Abstract][Full Text] [Related]
20. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation. Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]